| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |